JP3411146B2 - Body odor generation inhibitor - Google Patents
Body odor generation inhibitorInfo
- Publication number
- JP3411146B2 JP3411146B2 JP02200996A JP2200996A JP3411146B2 JP 3411146 B2 JP3411146 B2 JP 3411146B2 JP 02200996 A JP02200996 A JP 02200996A JP 2200996 A JP2200996 A JP 2200996A JP 3411146 B2 JP3411146 B2 JP 3411146B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- parts
- body odor
- generation
- odor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010040904 Skin odour abnormal Diseases 0.000 title claims description 63
- 208000035985 Body Odor Diseases 0.000 title claims description 58
- 239000003112 inhibitor Substances 0.000 title claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 238000010931 ester hydrolysis Methods 0.000 claims description 10
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 claims description 6
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 claims description 6
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims description 4
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 229940007550 benzyl acetate Drugs 0.000 claims description 3
- 235000017803 cinnamon Nutrition 0.000 claims description 3
- 229940067107 phenylethyl alcohol Drugs 0.000 claims description 3
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 claims description 2
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 claims description 2
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 claims description 2
- WJSDHUCWMSHDCR-VMPITWQZSA-N cinnamyl acetate Natural products CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 claims description 2
- 235000000484 citronellol Nutrition 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 2
- 241000723347 Cinnamomum Species 0.000 claims 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 claims 1
- 240000003768 Solanum lycopersicum Species 0.000 claims 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 24
- 239000002537 cosmetic Substances 0.000 description 16
- 239000000203 mixture Substances 0.000 description 15
- 235000014113 dietary fatty acids Nutrition 0.000 description 12
- 150000002148 esters Chemical class 0.000 description 12
- 239000000194 fatty acid Substances 0.000 description 12
- 229930195729 fatty acid Natural products 0.000 description 12
- 150000004665 fatty acids Chemical class 0.000 description 12
- 238000009472 formulation Methods 0.000 description 12
- 230000001629 suppression Effects 0.000 description 10
- 230000007062 hydrolysis Effects 0.000 description 9
- 238000006460 hydrolysis reaction Methods 0.000 description 9
- 235000019445 benzyl alcohol Nutrition 0.000 description 8
- 239000002453 shampoo Substances 0.000 description 7
- 230000001256 tonic effect Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000019645 odor Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 5
- 235000021588 free fatty acids Nutrition 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000004367 Lipase Substances 0.000 description 4
- 108090001060 Lipase Proteins 0.000 description 4
- 102000004882 Lipase Human genes 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000019421 lipase Nutrition 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 3
- 235000002566 Capsicum Nutrition 0.000 description 3
- 240000008574 Capsicum frutescens Species 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 3
- 239000001390 capsicum minimum Substances 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229940041616 menthol Drugs 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 229940098465 tincture Drugs 0.000 description 3
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 3
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- JOZKFWLRHCDGJA-UHFFFAOYSA-N citronellol acetate Chemical compound CC(=O)OCCC(C)CCC=C(C)C JOZKFWLRHCDGJA-UHFFFAOYSA-N 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000003676 hair preparation Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GJQIMXVRFNLMTB-UHFFFAOYSA-N nonyl acetate Chemical compound CCCCCCCCCOC(C)=O GJQIMXVRFNLMTB-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- MDHYEMXUFSJLGV-UHFFFAOYSA-N phenethyl acetate Chemical compound CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 2
- 229940117972 triolein Drugs 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- FRPAVHFNOFSNDR-UHFFFAOYSA-N 3-(2,4-dioxo-1,3-thiazolidin-3-yl)propanoic acid Chemical compound OC(=O)CCN1C(=O)CSC1=O FRPAVHFNOFSNDR-UHFFFAOYSA-N 0.000 description 1
- VAJVDSVGBWFCLW-UHFFFAOYSA-N 3-Phenyl-1-propanol Chemical compound OCCCC1=CC=CC=C1 VAJVDSVGBWFCLW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- JOZKFWLRHCDGJA-LLVKDONJSA-N Citronellyl acetate Natural products CC(=O)OCC[C@H](C)CCC=C(C)C JOZKFWLRHCDGJA-LLVKDONJSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropyl alcohol Natural products CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- QUMXDOLUJCHOAY-UHFFFAOYSA-N alpha-methylbenzyl acetate Natural products CC(=O)OC(C)C1=CC=CC=C1 QUMXDOLUJCHOAY-UHFFFAOYSA-N 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000019480 chamomile oil Nutrition 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- HIGQPQRQIQDZMP-UHFFFAOYSA-N geranil acetate Natural products CC(C)=CCCC(C)=CCOC(C)=O HIGQPQRQIQDZMP-UHFFFAOYSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- HIGQPQRQIQDZMP-DHZHZOJOSA-N geranyl acetate Chemical compound CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
【0001】[0001]
【発明の属する技術分野】本発明は、体臭の抑制に有益
な体臭発生抑制剤及びそれを含有する体臭抑制用の化粧
料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a body odor generation inhibitor useful for suppressing body odor, and a cosmetic containing the same for body odor suppression.
【0002】[0002]
【従来の技術】化粧料、取り分けボディー用化粧料や頭
髪用化粧料に於いて、頭髪臭或いはワキガ等の体臭の発
生を抑制することは重要なことであった。元来日本人は
その食生活が質素であった為、且つ、乳製品などの体臭
の発生を促進するような食品をあまり摂取しなかった
為、体臭の発生には気を配ることの必要性は少なかった
が、近年、食生活の西洋化と乳製品の摂取量の急増のた
めに体臭の発生が大きな問題となるに至っている。2. Description of the Related Art In cosmetics, especially body cosmetics and hair cosmetics, it is important to suppress the generation of body odors such as hair odors and armpits. Since Japanese originally had a simple diet, and did not ingest foods such as dairy products that promote the generation of body odor, it is necessary to be careful about the generation of body odor. However, in recent years, generation of body odor has become a serious problem due to westernization of eating habits and rapid increase in intake of dairy products.
【0003】この様な体臭に対して、従来からは、ジン
クピリチオンやイルガサン等の抗菌成分を配合し、体臭
の発生源と考えられる微生物の生育を抑制したデオドラ
ント製品や発生した体臭をシリカゲルやタルクなどの吸
着体によって吸着させ、拡散させることを抑制した製品
等が開発された。しかしながら、微生物は体臭の一因で
あっても、決定的な原因でないため微生物の抑制は体臭
抑制の根本的解決策とはならず、加えて抗菌成分には安
全性上問題があるものも少なくなかった。又、体臭の拡
散抑制も当然のことながら根本的解決策とはなり得なか
った。For such body odor, conventionally, antibacterial components such as zinc pyrithione and irgasan have been blended to suppress the growth of microorganisms, which are considered to be the source of body odor, and the generated body odor such as silica gel and talc. , Etc. have been developed by which the adsorbent of (3) suppresses the adsorption and diffusion. However, even if microorganisms are one of the causes of body odor, suppression of microorganisms is not a fundamental solution to the suppression of body odor, and in addition, few antibacterial components have safety problems. There wasn't. Also, the suppression of the diffusion of body odor could not be a fundamental solution as a matter of course.
【0004】一方、後記A群に示すエステル加水分解抑
制剤に体臭の抑制作用があることは全く知られていなか
った。On the other hand, ester hydrolysis inhibition shown in group A below
It was not known at all that the antibacterial agent had a body odor suppressing effect.
【0005】[0005]
【発明が解決しようとする課題】本発明はこの様な状況
を踏まえてなされたものであり、有効な体臭発生抑制剤
を提供することを課題とする。SUMMARY OF THE INVENTION The present invention has been made in view of such circumstances, and an object thereof is to provide an effective body odor generation inhibitor .
【0006】[0006]
【課題を解決するための手段】この様な状況に鑑みて、
本発明者等は体臭の抑制に有益なメカニズムを求めて鋭
意努力を重ねた結果、次に示すA群のエステル加水分解
抑制剤がその様な作用に優れていることを見いだし発明
を完成させた。これらの成分は、後述するように頭髪臭
などの体臭の原因となる、エステル類の加水分解に由来
する遊離脂肪酸の発生を抑制することにより、体臭の発
生を抑制する作用を有する。
(A)ベンジルアルコール、ベンジルアセテート、シン
ナミルアセテート、ネロール、桂皮アルコール、シトロ
ネロール、フェニルエチルアルコール [Means for Solving the Problems] In view of such a situation,
The present inventors have earnestly sought for a mechanism useful for suppressing body odor, and as a result, ester hydrolysis of group A shown below.
The inventors have found that the inhibitor is excellent in such action and completed the invention. These components have the action of suppressing the generation of body odor by suppressing the generation of free fatty acids derived from hydrolysis of esters, which cause body odor such as hair odor as described below. (A) Benzyl alcohol, benzyl acetate, syn
Namyl acetate, Nellore, cinnamon alcohol, Citro
Nellore, phenylethyl alcohol
【0007】(1)本発明の体臭発生抑制剤
本発明の体臭発生抑制剤は上記A群に示されるエステル
加水分解抑制剤からなる。これらのエステル加水分解抑
制剤は、何れも香料成分として広く用いられており、香
粧品における安全性は問題ない。又、これらは後記実施
例に示すように優れた体臭の原因である遊離脂肪酸の発
生を抑制し体臭の発生を抑制する作用を有する。本発明
のこれらのエステル加水分解抑制剤は何れも市販されて
おり入手に問題はない。本発明のエステル加水分解抑制
剤は唯一種を用いても良いし、二種以上を用いても良
い。(1) Body Odor Control Agent of the Present Invention The body odor control agent of the present invention is an ester shown in the above group A.
It consists of a hydrolysis inhibitor . These ester hydrolysis inhibitors
All of the agents are widely used as perfume ingredients, and there is no problem in safety in cosmetics. In addition, as shown in the Examples below, these are the generation of free fatty acids that cause excellent body odor.
It has the effect of suppressing rawness and suppressing the generation of body odor. All of these ester hydrolysis inhibitors of the present invention are commercially available and there is no problem in obtaining them. Inhibition of ester hydrolysis of the present invention
As the agent , only one kind may be used, or two or more kinds may be used.
【0008】(2)エステル加水分解と体臭の関係
本発明者等は、体臭を抑制する素材を求めて、体臭の発
生しやすいパネラー10名を用いて、体臭を発生させに
くい素材のスクリーニングを行った。その結果、ベンジ
ルアルコールがその様な作用に優れることを見いだし
た。そこで、そのメカニズムを探るために、ベンジルア
ルコールの有無によってどの様に頭皮の分泌物が異なる
かをガスクロマトグラフィーを用いて調べた。その結
果、ベンジルアルコールが存在することにより、脂肪酸
の生成が著しく抑制されることが確かめられた。ピーク
の形状からの脂肪酸発生の状況をを表1に示す。ここ
で、判定基準は++:著しい抑制、+:明らかな抑制、
±:僅かな抑制、抑制無し或いは発生促進:−を用い
た。これは、脂肪酸の発生量そのものの定量が脂肪酸の
種類の変化、ピーク形状の変化によって困難であったた
めである。一方、体臭の発生状況は、表2示す如くであ
り、表1の結果と良く相関していることが判る。この評
価基準は、++:著しい体臭発生の抑制、+:明かな体
臭発生の抑制、±:僅かな体臭発生の抑制、−:体臭の
発生の抑制無し或いは体臭の発生促進。これらの結果よ
り、体臭の発生の原因はエステル取り分けトリグリセラ
イドの加水分解による脂肪酸の発生であることが推測さ
れた。又、ベンジルアルコールそのもののピークに注目
すると、投与前に比べ投与後相対的に減じている様子が
うかがえた。又、ベンジルアルコールが存在したときに
見られる新規のピークがいくつか確認された。これはト
リグリセライドが加水分解して生じた脂肪酸とベンジル
アルコールが結合したエステルであると推測された。(2) Relationship between ester hydrolysis and body odor The present inventors searched for a material that suppresses body odor, and screened a material that does not easily produce body odor using 10 panelists who easily produce body odor. It was As a result, they have found that benzyl alcohol is excellent in such action. Therefore, to investigate the mechanism, we investigated how scalp secretions differ depending on the presence or absence of benzyl alcohol using gas chromatography. As a result, it was confirmed that the presence of benzyl alcohol significantly suppressed the production of fatty acids. Table 1 shows the status of fatty acid generation based on the peak shape. Here, the criterion is ++: remarkable suppression, +: clear suppression,
±: Slight suppression, no suppression or accelerated generation:-was used. This is because it was difficult to quantify the amount of fatty acid generated per se due to changes in the types of fatty acids and peak shapes. On the other hand, the generation status of body odor is as shown in Table 2, and it can be seen that it correlates well with the results in Table 1. The evaluation criteria are: ++: Remarkably suppressed body odor generation, +: Clear body odor generation, ±: Slight body odor generation,-: No body odor generation suppression or body odor generation promotion. From these results, it was speculated that the cause of body odor was the generation of fatty acids due to hydrolysis of ester and especially triglyceride. Also, focusing on the peak of benzyl alcohol itself, it was seen that the peak was relatively decreased after administration as compared with that before administration. Also, some new peaks were observed when benzyl alcohol was present. It was speculated that this was an ester in which a fatty acid generated by hydrolysis of triglyceride and benzyl alcohol were bonded.
【0009】[0009]
【表1】 [Table 1]
【0010】[0010]
【表2】 [Table 2]
【0011】次に、本発明者等は体臭取り分け頭髪臭の
原因のエステルの加水分解が何に起因して起こるかを考
察したところ、皮膚上のリパーゼ等のエステラーゼに思
い当たり、モデル実験を行った。即ち、スクワレン、コ
レステロール、グリセリルトリオレート、グリセリルト
リステアレートの等量混合物に、0.001%の割合で
ブタ膵臓由来のリパーゼを添加し、被験物質1重量%を
更に加えて、37℃で1日インキュベートした後、調香
師4名に頭髪臭との相似性を判定して貰った。コントロ
ールは、被験物質を添加せずに行った。結果は、臭気に
ついては、コントロールのサンプルの臭気については、
4名とも極めて頭髪臭と相似しているとのことだった。
又、バンジルアルコール添加系ではこの臭気は認められ
なかった。そこで、体臭の発生のモデルとして上記混合
系を用い、エステルの加水分解の度合いを指標に、これ
を抑制物質をスクリーニングした結果、下記の実施例に
示すように、上記A群の物質を見いだすに至った。これ
らの物質はエステルの加水分解を抑制し、頭髪臭などの
体臭が発生することを防ぐ作用に優れることが、後記実
施例に示すように見いだされた。これより、体臭の発生
とリパーゼに代表されるエステラーゼの作用に起因する
エステルの加水分解が非常に密接に関連していることが
判る。Next, the inventors of the present invention considered what caused the hydrolysis of the ester, which is the cause of body odor and hair odor, and thought of esterases such as lipase on the skin, and conducted a model experiment. . That is, to an equal mixture of squalene, cholesterol, glyceryl trioleate and glyceryl tristearate, 0.001% of lipase derived from porcine pancreas was added, and 1% by weight of the test substance was further added to the mixture at 37 ° C. After incubation for one day, four perfumers were asked to judge the similarity with the odor of hair. The control was performed without adding the test substance. The results show that for odors, for control sample odors,
It was said that all four had a very similar odor to hair.
In addition, this odor was not observed in the system containing vanzyl alcohol. Therefore, using the above-mentioned mixed system as a model of the generation of body odor, the degree of ester hydrolysis was used as an index, and a substance that suppresses this was screened. As a result, as shown in the following examples, the above-mentioned group A substances were found. I arrived. It was found that these substances are excellent in the action of suppressing the hydrolysis of the ester and preventing the generation of body odor such as hair odor, as shown in Examples below. From this, it is understood that the generation of body odor and the hydrolysis of the ester caused by the action of esterase represented by lipase are very closely related.
【0012】[0012]
【発明の実施の態様】本発明の実施の態様は、上記A群
に挙げる体臭発生抑制剤から選ばれる一種又は二種以上
を含有する事を特徴とする化粧料である。本発明の化粧
料は、体臭の抑制取り分け頭髪臭の抑制を目的に用いる
場合に優れた効果を発揮する。本発明の化粧料における
上記体臭発生抑制剤の好ましい含有量は、0.01〜1
0重量%であり、より好ましくは、0.05〜7重量%
であり、更に好ましくは、0.05〜5重量%である。
これらは、通常の方法によって、化粧料中に配合するこ
とが出来る。本発明の化粧料としては、ヘアクリーム、
ヘアトニック、シャンプー、リンス、トリートメント、
ヘアオイル等の頭髪用の化粧料やボディーマッサージ
料、ボディーローション、ボディーパウダー、ボディー
クレンジング等のボディー用の化粧料が好ましく、中で
も頭髪用の化粧料が好ましい。本発明の化粧料は、上記
エステル加水分解抑制剤以外に通常化粧料で用いられて
いる任意の成分を配合することが出来る。この様な任意
成分としては、例えば、ワセリンやマイクロクリスタリ
ンワックス等のような炭化水素類、ホホバ油やゲイロウ
等のエステル類、牛脂、オリーブ油等のトリグリセライ
ド類、セタノール、オレイルアルコール等の高級アルコ
ール類、ステアリン酸、オレイン酸等の脂肪酸、グリセ
リンや1,3−ブタンジオール等の多価アルコール類、
非イオン界面活性剤、アニオン界面活性剤、カチオン界
面活性剤、両性界面活性剤、エタノール、カーボポール
等の増粘剤、防腐剤、紫外線吸収剤、抗酸化剤、色素、
香料、粉体類等が挙げられる。更に、抗菌剤などのデオ
ドラント料なども配合できる。以下に、例を挙げて本発
明の実施の態様について更に詳しく説明する。BEST MODE FOR CARRYING OUT THE INVENTION An embodiment of the present invention is a cosmetic characterized in that it contains one or more selected from the body odor generation inhibitors listed in Group A above. The cosmetic of the present invention exerts an excellent effect when used for the purpose of suppressing body odor and especially suppressing hair odor. The preferable content of the body odor generation inhibitor in the cosmetic of the present invention is 0.01 to 1
0% by weight, more preferably 0.05 to 7% by weight
And more preferably 0.05 to 5% by weight.
These can be blended in the cosmetic by a usual method. The cosmetics of the present invention include hair cream,
Hair tonic, shampoo, conditioner, treatment,
Hair oils and other cosmetics for hair and body massages, body lotions, body powders, body cleansings and other body cosmetics are preferred, and hair cosmetics are particularly preferred. The cosmetics of the present invention may contain any components commonly used in cosmetics other than the ester hydrolysis inhibitor. Such optional components include, for example, hydrocarbons such as petrolatum and microcrystalline wax, esters such as jojoba oil and gallow, beef tallow, triglycerides such as olive oil, cetanol, higher alcohols such as oleyl alcohol, Fatty acids such as stearic acid and oleic acid, polyhydric alcohols such as glycerin and 1,3-butanediol,
Nonionic surfactants, anionic surfactants, cationic surfactants, amphoteric surfactants, thickeners such as ethanol and carbopol, preservatives, ultraviolet absorbers, antioxidants, pigments,
Examples include fragrances and powders. Further, a deodorant material such as an antibacterial agent may be added. Hereinafter, embodiments of the present invention will be described in more detail with reference to examples.
【0013】(例1)ヘアトニック
下記処方に従って、ヘアトニックを作成した。即ち、処
方成分を室温で攪拌可溶化しヘアトニックを得た。
エタノール 60 重量部
メントール 0.1重量部
ベンジルアルコール 0.1重量部
トウガラシチンキ 0.1重量部
POE(60)硬化ヒマシ油 0.1重量部
ビタミンEニコチネート 0.1重量部
水 39.5重量部Example 1 Hair Tonic A hair tonic was prepared according to the following formulation. That is, the formulation components were stirred and solubilized at room temperature to obtain a hair tonic. Ethanol 60 parts by weight Menthol 0.1 parts by weight Benzyl alcohol 0.1 parts by weight Capsicum tincture 0.1 parts by weight POE (60) hydrogenated castor oil 0.1 parts by weight Vitamin E nicotinate 0.1 parts by weight water 39.5 parts by weight
【0014】(例2)ヘアトニック
下記処方に従って、ヘアトニックを作成した。即ち、処
方成分を室温で攪拌可溶化しヘアトニックを得た。
エタノール 60 重量部
メントール 0.1重量部
桂皮アルコール 0.1重量部
トウガラシチンキ 0.1重量部
POE(60)硬化ヒマシ油 0.1重量部
ビタミンEニコチネート 0.1重量部
水 39.5重量部Example 2 Hair Tonic A hair tonic was prepared according to the following formulation. That is, the formulation components were stirred and solubilized at room temperature to obtain a hair tonic. Ethanol 60 parts by weight Menthol 0.1 parts by weight Cinnamon alcohol 0.1 parts by weight Capsicum tincture 0.1 parts by weight POE (60) hydrogenated castor oil 0.1 parts by weight Vitamin E nicotinate 0.1 parts by weight water 39.5 parts by weight
【0015】(例3)ヘアトニック
下記処方に従って、ヘアトニックを作成した。即ち、処
方成分を室温で攪拌可溶化しヘアトニックを得た。
エタノール 60 重量部
メントール 0.1重量部
ベンジルアセテート 0.1重量部
トウガラシチンキ 0.1重量部
POE(60)硬化ヒマシ油 0.1重量部
ビタミンEニコチネート 0.1重量部
水 39.5重量部Example 3 Hair Tonic A hair tonic was prepared according to the following formulation. That is, the formulation components were stirred and solubilized at room temperature to obtain a hair tonic. Ethanol 60 parts by weight Menthol 0.1 parts by weight Benzyl acetate 0.1 parts by weight Capsicum tincture 0.1 parts by weight POE (60) hydrogenated castor oil 0.1 parts by weight Vitamin E nicotinate 0.1 parts by weight water 39.5 parts by weight
【0016】(例4)シャンプー
下記処方に従って、シャンプーを作成した。即ち、処方
成分を室温で攪拌可溶化しシャンプーを得た。
ラウリル硫酸ナトリウム 10 重量部
POE(20)ラウリル硫酸ナトリウム 10 重量部
プロピレングリコール 10 重量部
シンナミルアセテート 0.1重量部
シトロネロール 0.5重量部
ゲラニオール 0.5重量部
ネロール 0.1重量部
ノニルアセテート 0.1重量部
水 68.7重量部Example 4 Shampoo A shampoo was prepared according to the following formulation. That is, the prescription ingredients were stirred and solubilized at room temperature to obtain a shampoo. Sodium lauryl sulfate 10 parts by weight POE (20) Sodium lauryl sulfate 10 parts by weight Propylene glycol 10 parts by weight Cinnamyl acetate 0.1 parts by weight Citronellol 0.5 parts by weight Geraniol 0.5 parts by weight Nellore 0.1 parts by weight Nonyl acetate 0 .1 part by weight water 68.7 parts by weight
【0017】(例5)ボデイーシャンプー
下記処方に従って、ボディーシャンプーを作成した。即
ち、処方成分を室温で攪拌可溶化しボディーシャンプー
を得た。
ラウリル硫酸ナトリウム 10 重量部
ラウリン酸トリエタノールアミン 10 重量部
プロピレングリコール 10 重量部
フェニルエチルアルコール 0.1重量部
フェニルプロピルアルコール 0.5重量部
カモミールオイル 0.5重量部
ローズドメイオイル 0.1重量部
ゲラニルアセテート 0.1重量部
水 68.7重量部Example 5 Body Shampoo A body shampoo was prepared according to the following formulation. That is, the formulation ingredients were stirred and solubilized at room temperature to obtain a body shampoo. Sodium lauryl sulfate 10 parts by weight Triethanolamine laurate 10 parts by weight Propylene glycol 10 parts by weight Phenylethyl alcohol 0.1 parts by weight Phenylpropyl alcohol 0.5 parts by weight Chamomile oil 0.5 parts by weight Rosed May oil 0.1 parts by weight Geranyl acetate 0.1 part by weight water 68.7 parts by weight
【0018】(例6)ボデイーパウダー
下記処方成分をヘンシェルミキサーで混合し、1mm丸
穴スクリーンを装着したパルベライザーで粉砕し、金皿
に詰め加圧成型しボディーパウダーを得た。
スクワラン 5 重量部
タルク 48.3重量部
セリサイト 30 重量部
マイカ 15 重量部
ベンジルアルコール 0.5重量部
シトロネリルアセテート 0.1重量部
フェニルエチルアセテート 0.1重量部(Example 6) Body powder The following ingredients were mixed in a Henschel mixer, pulverized with a pulverizer equipped with a 1 mm round hole screen, packed in a gold plate and pressure-molded to obtain a body powder. Squalane 5 parts by weight Talc 48.3 parts by weight Sericite 30 parts by weight Mica 15 parts by weight Benzyl alcohol 0.5 parts by weight Citronellyl acetate 0.1 parts by weight Phenylethyl acetate 0.1 parts by weight
【0019】(例7)化粧水
下記処方に従って化粧水を作成した。即ち、処方成分を
室温で攪拌可溶化し化粧水を得た。
グリセリン 5 重量部
1,3−ブタンジオール 8 重量部
メチルパラベン 0.2重量部
エタノール 10 重量部
桂皮アルデヒド 0.2重量部
水 76.5重量部
ヒアルロン酸ナトリウム 0.1重量部(Example 7) Lotion A lotion was prepared according to the following formulation. That is, the formulation ingredients were stirred and solubilized at room temperature to obtain a lotion. Glycerin 5 parts by weight 1,3-butanediol 8 parts by weight Methylparaben 0.2 parts by weight Ethanol 10 parts by weight Cinnamaldehyde 0.2 parts by weight Water 76.5 parts by weight Sodium hyaluronate 0.1 parts by weight
【0020】[0020]
【実施例】以下に実施例を示し、本発明の効果について
詳細に説明する。EXAMPLES The effects of the present invention will be described in detail below with reference to examples.
【0021】実施例1
エステルの加水分解による脂肪酸の遊離と体臭様臭気の
発生
下記処方の混合物を37℃で1日インキュベートした
後、ガスクロマトグラフィー(カラム:HP−5、15
m×0.25mm、ヒューレットパッカード社製;キャ
リアーガス:ヘリウム;流速:1.0ml/min;オ
ーブン温度:150→320℃(8℃/min);イン
レット温度:320℃、ディテクター温度:330℃;
検知:FID)でエステル体、遊離脂肪酸量を測定し、
その後、調香師により体臭様の匂いの強度を判定して貰
った。尚、コントロールは体臭発生抑制剤を流動パラフ
ィンに置き換えたものを用いた。結果を表3に示す。こ
れより、本発明の体臭発生抑制剤がエステルの加水分解
を抑制し遊離脂肪酸両が抑制されていることが判る。
又、これに比例して体臭様の匂いの発生も抑制されてい
ることが判る。
(サンプルの処方)
スクワラン 25 重量部
コレステロール 25 重量部
グリセリルトリオレート 25 重量部
グリセリルトリステアレート 25 重量部
リパーゼ(豚膵臓由来) 0.001重量部
体臭発生抑制剤 1 重量部
(エステルの残存量の判定基準;コントロールに比較し
て)
++:残存量が非常に多い、+:残存量が明らかに多
い、±:残存量がやや多い、−:コントロールと変わら
ない
(遊離脂肪酸の判定基準;コントロールに比較して)
++:脂肪酸が非常に少ない、+:脂肪酸量が明らかに
少ない、±:脂肪酸量がやや少ない、−:コントロール
と変わらない
(体臭様匂いの発生;コントロールと比較して)
++:非常に少ない、+:明らかに少ない、±:やや少
ない、−:コントロールと変わらないExample 1 Release of fatty acid and generation of body odor by hydrolysis of ester The mixture of the following formulation was incubated at 37 ° C. for 1 day and then subjected to gas chromatography (column: HP-5, 15).
m × 0.25 mm, manufactured by Hewlett Packard; carrier gas: helium; flow rate: 1.0 ml / min; oven temperature: 150 → 320 ° C. (8 ° C./min); inlet temperature: 320 ° C., detector temperature: 330 ° C .;
Detection: FID) to measure the amount of ester and free fatty acid,
After that, the perfumer judged the intensity of body odor. As the control, liquid paraffin was used as the body odor generation inhibitor. The results are shown in Table 3. From this, it is understood that the body odor generation inhibitor of the present invention suppresses the hydrolysis of the ester and the free fatty acid is suppressed.
Further, it is understood that the generation of body odor is suppressed in proportion to this. (Sample prescription) Squalane 25 parts by weight Cholesterol 25 parts by weight Glyceryl trioleate 25 parts by weight Glyceryl tristearate 25 parts by weight Lipase (from pig pancreas) 0.001 parts by weight Body odor suppressant 1 part by weight (of residual amount of ester) criterion; compared to controls) ++: remaining amount is very large, +: remaining amount is clearly greater, ±: remaining amount slightly more, -: not different from controls (criteria of free fatty acids; the control ++: Very low amount of fatty acid, +: Clearly low amount of fatty acid, ±: Moderate low amount of fatty acid, −: Same as control (occurrence of body odor-like odor; compared with control) ++: Very few, +: Remarkably less, ±: Somewhat less,-: Same as control
【0022】[0022]
【表3】 [Table 3]
【0023】実施例2
官能テスト
発明の実施の態様の例1〜例7の化粧料を、これらの体
臭発生抑制剤抑制剤を水に置き換えた比較例1〜比較例
7を専門パネラー5名に1週間づつ使用して貰い体臭の
発生の抑制を評価して貰った。結果を表4に示す。これ
より、本発明の体臭発生抑制剤を含有する化粧料は、体
臭発生を抑制していることが判る。Example 2 Sensory Test For the cosmetics of Examples 1 to 7 of the embodiment of the invention, Comparative Examples 1 to 7 in which these body odor suppressors and inhibitors were replaced with water were designated by 5 specialized panelists. It was used once a week to evaluate the suppression of body odor generation. The results are shown in Table 4. From this, it can be seen that the cosmetic containing the body odor suppressor of the present invention suppresses body odor generation.
【0024】[0024]
【表4】 [Table 4]
【0025】[0025]
【発明の効果】本発明の体臭発生抑制剤は、体臭の発生
の原因である、エステル加水分解によって生じる脂肪酸
の遊離を抑制する作用に優れるので、これを含有する化
粧料は体臭を抑制する作用に優れる。The body odor suppressor of the present invention is a fatty acid produced by ester hydrolysis, which is a cause of body odor.
Since it has an excellent effect of suppressing the liberation of lactic acid, a cosmetic containing the same has an excellent effect of suppressing body odor.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI A61K 7/075 A61K 7/075 7/50 7/50 (72)発明者 石戸谷 豊昌 神奈川県横浜市神奈川区高島台27番地1 ポーラ化成工業株式会社 横浜研究所 内 (56)参考文献 特開 平6−253924(JP,A) 特開 平5−255689(JP,A) 特開 平6−179610(JP,A) 特開 平9−187297(JP,A) 特表 平11−512132(JP,A) (58)調査した分野(Int.Cl.7,DB名) A61K 7/32 A61K 7/00 A61K 7/06 A61K 7/075 A61K 7/50 CA(STN)─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 7 Identification code FI A61K 7/075 A61K 7/075 7/50 7/50 (72) Inventor Toyomasa Ishitoya 27 Takashimadai, Kanagawa-ku, Yokohama, Kanagawa Prefecture 1 Pola Chemical Industry Co., Ltd. Yokohama Laboratory (56) Reference JP-A-6-253924 (JP, A) JP-A-5-255689 (JP, A) JP-A-6-179610 (JP, A) JP Flat 9-187297 (JP, A) Special table Flat 11-512132 (JP, A) (58) Fields surveyed (Int.Cl. 7 , DB name) A61K 7/32 A61K 7/00 A61K 7/06 A61K 7 / 075 A61K 7/50 CA (STN)
Claims (2)
ト、シンナミルアセテート、ネロール、桂皮アルコー
ル、シトロネロール及びフェニルエチルアルコールから
選択されるエステル加水分解抑制剤の少なくとも1種か
らなる体臭発生抑制剤。1. Benzyl alcohol, benzyl acetate
Tomato, cinnamyl acetate, nerol, cinnamon alcohol
From citronellol and phenylethyl alcohol
At least one ester hydrolysis inhibitor selected
A body odor generation inhibitor consisting of .
記載の体臭発生抑制剤。2. A method according to claim 1 body odor is hair odor or Wakiga
The body odor generation inhibitor described.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP02200996A JP3411146B2 (en) | 1996-01-12 | 1996-01-12 | Body odor generation inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP02200996A JP3411146B2 (en) | 1996-01-12 | 1996-01-12 | Body odor generation inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09194339A JPH09194339A (en) | 1997-07-29 |
JP3411146B2 true JP3411146B2 (en) | 2003-05-26 |
Family
ID=12071013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP02200996A Expired - Fee Related JP3411146B2 (en) | 1996-01-12 | 1996-01-12 | Body odor generation inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3411146B2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19757508A1 (en) * | 1997-12-23 | 1999-06-24 | Henkel Kgaa | Compositions for enhancing hair shine |
JP3717676B2 (en) * | 1998-09-09 | 2005-11-16 | 株式会社カネボウ化粧品 | Hair nourishing |
MXPA01002807A (en) * | 1998-09-17 | 2004-03-19 | Exxon Chemical Patents Inc | Cosmetic compositions containing higher alkyl acetates as emollients. |
KR20000056964A (en) * | 1999-02-04 | 2000-09-15 | 윤광렬 | Tissue containing natural essential oil for post-treatmint of urination |
JP2002255774A (en) * | 2001-03-02 | 2002-09-11 | Kao Corp | Deodorant |
US20070207113A1 (en) * | 2006-02-10 | 2007-09-06 | Melissa Joerger | Personal care and cosmetic compositions comprising renewably-based, biodegradable 1,3-propanediol |
JP5962508B2 (en) * | 2010-09-02 | 2016-08-03 | ライオン株式会社 | Shampoo composition |
JP5678523B2 (en) * | 2010-09-02 | 2015-03-04 | ライオン株式会社 | Cosmetic composition |
JP5992306B2 (en) * | 2011-12-13 | 2016-09-14 | 大正製薬株式会社 | Oral body odor improving composition |
-
1996
- 1996-01-12 JP JP02200996A patent/JP3411146B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH09194339A (en) | 1997-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69001730T2 (en) | PASTE-SHAPED, AQUEOUS PHARMACEUTICAL COMPOSITIONS. | |
CA2132369C (en) | Use for the treatment of mixed skins, of an effective quantity of active substances | |
US20040254245A1 (en) | Cosmetic and dermopharmaceutical compositions for skin prone to acne | |
AU780426B2 (en) | Method for reducing the appearance of dark circles under the eyes | |
JP3739803B2 (en) | Novel antimicrobial cosmetic composition | |
EP1875902B1 (en) | Sedative effect-providing agent and sedative fragrance composition containing the same | |
JP3411146B2 (en) | Body odor generation inhibitor | |
US20060093689A1 (en) | Skin cosmetics | |
JP2002161027A (en) | Method for suppressing inflammation and erythema and composition therefor | |
JPH11315012A (en) | Cyclic amp inducing agent | |
JPWO2012042970A1 (en) | Preventive or therapeutic agent for atopic dermatitis, and external preparation | |
JPH09194340A (en) | Agent for inhibiting hydrolysis of ester and cosmetic containing the same | |
JPH1179951A (en) | Tyrosinase activity promoter | |
JP2006298814A (en) | Skin lotion for acne | |
JP2001302483A (en) | Deodorant | |
JP2001207188A (en) | Perfume composition for eliminating lipid peroxide | |
JP2002179519A (en) | Method and composition for ameliorating condition of clear skin | |
JP2003104867A (en) | Skin care preparation | |
EP1093354A1 (en) | Method of reducing or preventing malodour | |
JPH10265340A (en) | Composition for head containing methylenedioxybenzene ring-aliphatic compound | |
JPH0655664B2 (en) | Beautiful skin cosmetics | |
JP2005194290A (en) | Cleansing cosmetic | |
JP2832621B2 (en) | Skin, scalp and hair cosmetics containing dandruff growth inhibitor consisting of plant-derived extracts | |
JP2011207808A (en) | Antibacterial agent | |
JPH0456002B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120320 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150320 Year of fee payment: 12 |
|
LAPS | Cancellation because of no payment of annual fees |